| Mailing address: |
Elina Daamen, media relations
NV Organon
Page: 1 2 3
Related medicine technology :
1. Data Available From Erbitux Phase III Study in First-Line Treatment
of Advanced Lung Cancer
2. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral
Anticoagulant, Presented Today at the XXIst Congress of the
International Society on Thrombosis and Haemostasis
3. YM BioSciences Announces Secondary Efficacy and Safety Findings in
Randomized Phase IIB Aerolef Trial
4. Portola Pharmaceuticals Announces Positive Data from a Phase II
Study of its Factor Xa Inhibitor at the XXI Congress of the
International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for
Oral Oleoyl-estrone
6. Actemra (tocilizumab) Third Phase III Study Results Show
Significant Improvement in Symptoms of Patients with Rheumatoid
Arthritis
7. AVI BioPharma Partner Cook Medical Announces Completion of Patient
Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of
Cardiovascular Disease
8. NexMed Announces Completion of Patient Enrollment in Two Pivotal
Phase 3 Studies for Anti-Fungal Product
9. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial
with Alkaline Phosphatase For Ulcerative Colitis
10. Phase III Trial Results Show Superiority of Rivaroxaban over
Enoxaparin for the Prevention of Venous Thromboembolism in Patients
Undergoing Knee Replacement Surgery
11. Phase III Trial Results Show Superiority of Rivaroxaban over
Enoxaparin for the Prevention of Venous Thromboembolism in Patients
Undergoing Knee Replacement Surgery
(Date:11/25/2009)...if., Nov. 25 AMPAC Fine Chemicals ...ation (Nasdaq: APFC ) announced today that it rec...ability Award at the Annual Statewide Environmenta...s and Technology Association (CMTA), the Industria... Industry Council of California (CICC) held in San... (Date:11/25/2009)...Nov. 25 Abaxis, Inc. (Na...uring point-of-care blood analysis systems, announ...executive officer, will present at the 21st Annual..., December 2, 2009 at 2:00 p.m. ET. The conference...York City. ,, About Abaxis ,, Abaxis deve... (Date:11/25/2009).... 25 Reportlinker.com announces th...s catalogue: ,, Pain Management - Global Tren...ain-Management---Global-Trends.html ,, Widespr...in management clinics, and the advent of new drugs...anagement market. Healthcare reforms and reimburse... Breaking Medicine Technology:AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 3Reportlinker Adds Pain Management - Global Trends 2Reportlinker Adds Pain Management - Global Trends 3Reportlinker Adds Pain Management - Global Trends 4Reportlinker Adds Pain Management - Global Trends 5Reportlinker Adds Pain Management - Global Trends 6Open Letter to Congress on Long Term Care Insurance and Health Care Reform 58188 1Open Letter to Congress on Long Term Care Insurance and Health Care Reform 58188 2Leader in Elder Care Award to Posit Science CEO 58186 1Leader in Elder Care Award to Posit Science CEO 58186 2Shady Grove Fertility Center Presents 5K Fundraising Race to Help Families Afford Fertility Treatment or Adoption 58184 1Shady Grove Fertility Center Presents 5K Fundraising Race to Help Families Afford Fertility Treatment or Adoption 58184 2Shady Grove Fertility Center Presents 5K Fundraising Race to Help Families Afford Fertility Treatment or Adoption 58184 3...7 APA Meeting Also Showed No,Significant Impact on..., Pa., May 21, 2007 /PRNewswire-FirstCall/ --,Find...ning the,effect of desvenlafaxine succinate on anx...sociated with major depressive disorder,(MDD) -- a... the,effect of desvenlafaxine succinate on weight ... ...ting -, COLLEGEVILLE, Pa., May 21, 2007 /PRNewswir...ng safety and efficacy of,desvenlafaxine succinate...NRI) being studied as a potential treatment for ad...esented today at the,2007 American Psychiatric Ass...yeth Pharmaceuticals, a division of Wyeth . Result... Other Medicine Technology:Pooled Studies Showed Desvenlafaxine Succinate Significantly,Improved Painful Symptoms and Anxious Symptoms Associated with,Major Depressive Disorder in Adults, Compared With Placebo 2Pooled Studies Showed Desvenlafaxine Succinate Significantly,Improved Painful Symptoms and Anxious Symptoms Associated with,Major Depressive Disorder in Adults, Compared With Placebo 3Pooled Studies Showed Desvenlafaxine Succinate Significantly,Improved Painful Symptoms and Anxious Symptoms Associated with,Major Depressive Disorder in Adults, Compared With Placebo 4Pooled Studies Showed Desvenlafaxine Succinate Significantly,Improved Painful Symptoms and Anxious Symptoms Associated with,Major Depressive Disorder in Adults, Compared With Placebo 5Pooled Studies Showed Desvenlafaxine Succinate Significantly,Improved Painful Symptoms and Anxious Symptoms Associated with,Major Depressive Disorder in Adults, Compared With Placebo 6New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 2New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 3New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 4New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 5New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 6New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 7New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 8(Date:11/27/2009).... 27 The Gymboree Corpor...t, CFO/COO, will present at the NASDAQ OMX 23rd In... Hotel in London, England, on Wednesday, December ...ive broadcast of The Gymboree Corporation,s presen...boree.com, click on "Our Company" at the bottom of... (Date:11/27/2009)...aCare Holdings has announced that it has become a ...of the largest nonprofit organizations dedicated t... , Delray Beach, FL (Vocus...CBB: XCHO), a company specializing in the marketin...roducts, has announced today that is has become a ... (Date:11/27/2009)...ant Health™ announced today that Spectrum He...umaCad Enterprise orthopedic templating solution a... (PRWEB) November 27, 2009 -- V...Health (Grand Rapids, Michigan) has licensed its T... and its TraumaCad Extend workflow solution, to al... (Date:11/26/2009)... With cold and flu season upon us,...tices to control the spread of infections and avoi... to keep ourselves healthy, but to avoid transmitt...N, MS, CIC (certified in infection-control), nursi... health at Hospital for Special Surgery (HSS) in M... (Date:11/26/2009)... heavy can lead to strains or worse , , ... nothing wrong with stuffing your turkey full to b...ng with your suitcase as you pack for holiday trip...08 in U.S. hospital emergency rooms, doctors, offi...age-related injuries, such as muscle strains, pull... Breaking Medicine News(10 mins):Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 4Health News:Pack Right for the Holidays to Avoid the ER 2...uted EPS guidance for ,08, ,09, ,10, Dey expecte...uted EPS, PITTSBURGH, Sept. 8 Following the comp...rnatives for Dey, L.P., Mylan,Inc.,s (NYSE: MYL )...rming its adjusted diluted,EPS guidance for 2008, ... ...for International Development (USAID) has awarded ...f North Carolina at Chapel Hill up to $181 million...e award is the largest ever received by UNC. , Th...ect also monitors and evaluates malaria, tuberculo... ...h Plan Arizona announced,today that healthcare vet...regional sales director. SCAN currently offers a h...viduals in the greater Phoenix area and also,provi... president at Baltimore-based,Bravo Health, a mult... ... Cancer Center at Children,s Hospital of ...ept. 8 aloft(SM) hotels, Starwood Hotels,and Reso... brand, which,opened in Philadelphia on 8.8.08, co...iladelphia suburb and Havertown native, Hansen won... ... influence the link, study finds , , MONDA...or less of sleep a night increases the risk of fal...y. , It also found that the use of sleep medicatio... spent sleeping) and frequency of falls in 2,978 w... ...alpha (IKKα) regulates the cell cycle of ker...pecialized skin cells from becoming malignant, res... Cancer Center report in the Sept. 9 issue of Canc...rst mouse model of its kind, we also found that de... Other Medicine News:Health News:Mylan to Retain Dey, L.P., Its Specialty Pharmaceutical Subsidiary 2Health News:Mylan to Retain Dey, L.P., Its Specialty Pharmaceutical Subsidiary 3Health News:Mylan to Retain Dey, L.P., Its Specialty Pharmaceutical Subsidiary 4Health News:UNC receives record $181 million grant to evaluate health, poverty and gender programs worldwide 2Health News:Healthcare Executive Richard Peitzmeier Returns to Phoenix as Regional Sales Director of SCAN Health Plan Arizona 2Health News:aloft(SM) hotels Congratulates Hometown Olympic Swimmer and Gold Medalist Brendan Hansen Friday, September 12, 2008 2Health News:Fall Risk Higher in Older Women Who Sleep Less 2Health News:Protein 'switch' suppresses skin cancer development 2Health News:Protein 'switch' suppresses skin cancer development 3Smart CompuBand Kisses mother/infant matching Hugs infant protection system AgileTrac™ Infant Security Medicine Products: |
